Fludarabine phosphate and cyclophosphamide combined with immunotherapy (rituximab) once weekly is safe and highly effective in older patients with indolent B-NHL

Bross, K. and Berand, A. and Reichle, A. and Demandt, M. and Fischer von Weikersthal, L. and Funk, R. and Andreesen, R. (2005) Fludarabine phosphate and cyclophosphamide combined with immunotherapy (rituximab) once weekly is safe and highly effective in older patients with indolent B-NHL. In: 9th International Conference on Malignant Lymphoma, June 09-11, 2005, Lugano, Switzerland.

Full text not available from this repository.
Item Type: Conference or Workshop Item (UNSPECIFIED)
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 14 Apr 2022 06:44
Last Modified: 14 Apr 2022 06:44
URI: https://pred.uni-regensburg.de/id/eprint/36019

Actions (login required)

View Item View Item